A meta-analysis showed that CTLA-4 +49A/G polymorphism may be a risk factor for cancer, whereas -318C/T and +6230G/A (CT60) polymorphisms were lack of association with cancer [4]. This evidence concerns the gene CTLA4 and cancer.